A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.

NCT04323306 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: MMV688533

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]
[object Object]